Algert Global LLC Raises Holdings in Progyny, Inc. (NASDAQ:PGNY)

Algert Global LLC raised its position in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 138.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 184,885 shares of the company's stock after purchasing an additional 107,432 shares during the quarter. Algert Global LLC owned 0.20% of Progyny worth $3,099,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of Progyny by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 8,311,840 shares of the company's stock valued at $317,097,000 after buying an additional 41,687 shares during the period. International Assets Investment Management LLC lifted its holdings in shares of Progyny by 1,576.0% in the 3rd quarter. International Assets Investment Management LLC now owns 2,565,118 shares of the company's stock valued at $42,991,000 after buying an additional 2,412,068 shares during the period. Pacer Advisors Inc. lifted its holdings in shares of Progyny by 12,579.4% in the 3rd quarter. Pacer Advisors Inc. now owns 2,492,642 shares of the company's stock valued at $41,777,000 after buying an additional 2,472,983 shares during the period. Farallon Capital Management LLC lifted its holdings in shares of Progyny by 120.8% in the 2nd quarter. Farallon Capital Management LLC now owns 1,308,500 shares of the company's stock valued at $37,436,000 after buying an additional 715,900 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Progyny by 24.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,281,928 shares of the company's stock valued at $36,676,000 after buying an additional 254,725 shares during the period. Hedge funds and other institutional investors own 94.93% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on PGNY shares. BTIG Research cut Progyny from a "buy" rating to a "neutral" rating in a report on Wednesday, August 7th. Canaccord Genuity Group reduced their price target on Progyny from $18.00 to $17.00 and set a "hold" rating for the company in a report on Wednesday, November 13th. JPMorgan Chase & Co. reduced their price target on Progyny from $31.00 to $22.00 and set an "overweight" rating for the company in a report on Thursday, September 19th. Canaccord Genuity Group cut Progyny from a "buy" rating to a "hold" rating and reduced their price target for the stock from $37.00 to $24.00 in a report on Wednesday, August 7th. Finally, Leerink Partnrs cut Progyny from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 7th. Eight equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $25.42.

Progyny Stock Performance

Shares of PGNY stock traded down $0.48 during trading hours on Tuesday, reaching $15.27. The company had a trading volume of 1,389,441 shares, compared to its average volume of 1,402,722. The stock has a fifty day moving average of $16.23 and a 200-day moving average of $22.49. The company has a market capitalization of $1.30 billion, a price-to-earnings ratio of 26.33, a PEG ratio of 1.78 and a beta of 1.44. Progyny, Inc. has a 12-month low of $13.39 and a 12-month high of $42.08.

Progyny (NASDAQ:PGNY - Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by ($0.26). The company had revenue of $286.63 million during the quarter, compared to analysts' expectations of $296.85 million. Progyny had a net margin of 5.03% and a return on equity of 11.36%. Progyny's revenue for the quarter was up 2.0% on a year-over-year basis. During the same quarter last year, the company earned $0.16 earnings per share. On average, analysts forecast that Progyny, Inc. will post 0.58 EPS for the current year.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.